Cross-stage and combination treatment for Barcelona Clinic of Liver Cancer stage B (intermediate stage) hepatocellular carcinoma

2012 ◽  
Vol 27 (6) ◽  
pp. 991-993 ◽  
Author(s):  
Sheng-Nan Lu
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Cancer ◽  
Combination Treatment ◽  
Intermediate Stage ◽  
Cancer Stage

scholarly journals Unresectable hepatocellular carcinoma treatment with doxorubicin-eluting polyethylene glycol microspheres: a single-center experience

2021 ◽  
pp. HEP38
Author(s):  
Gerardo Tovar-Felice ◽  
Andrés García-Gámez ◽  
Virgilio Benito-Santamaría ◽  
David Balaguer-Paniagua ◽  
Jordi Villalba-Auñón ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Cancer ◽  
Tumor Response ◽  
Intermediate Stage ◽  
Complete Response ◽  
Barcelona Clinic Liver Cancer ◽  
Cancer Stage ◽  
Single Center Experience ◽  
Unresectable Hepatocellular Carcinoma ◽  
Small Cohort

Background: Transarterial chemoembolization (TACE) is indicated for unresectable hepatocellular carcinoma. Methods: This was a retrospective study of 50 hepatocellular carcinoma patients treated with TACE using doxorubicin-loaded LifePearl™ to investigate the safety and efficacy of TACE. Results: There was no 30-day mortality, and limited adverse events were reported. At best tumor response, complete response and disease control were 58% and 94%, respectively, with a median of 4.5 months of follow-up. Median overall survival was 33.8 months. Patients with Barcelona Clinic Liver Cancer stage 0 and stage A at best tumor response showed a higher complete response rate (83%) than patients with Barcelona Clinic Liver Cancer stage B (complete response: 50%; p = 0.0414). Conclusion: Doxorubicin-loaded LifePearl™ TACE might be an effective treatment, with a good safety profile, for patients with early/intermediate-stage hepatocellular carcinoma. Further prospective data, especially with a small cohort of selected patients, are required to confirm these results.

Application of BCLC-B subclassification and Hong Kong Liver Cancer Systems to intermediate stage hepatocellular carcinoma

2020 ◽  
Vol 52 ◽  
pp. e54
Author(s):  
G. Ricco ◽  
C.O. Demirtas ◽  
F. Oliveri ◽  
P. Colombatto ◽  
O.C. Ozdogan ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hong Kong ◽  
Liver Cancer ◽  
Intermediate Stage

Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C

2013 ◽  
Vol 45 (6) ◽  
pp. 510-515 ◽  
Author(s):  
Jing-Houng Wang ◽  
Yuan-Hung Kuo ◽  
Chih-Chi Wang ◽  
Chao-Long Chen ◽  
Yu-Fen Cheng ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Cancer ◽  
Surgical Resection ◽  
Barcelona Clinic Liver Cancer ◽  
Cancer Stage
Sign in / Sign up

Export Citation Format

Share Document